Publication

Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity

Related publications (111)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity

Graph Chatbot

Chat with Graph Search

Interactions between fibroblastic reticular cells and B cells promote mesenteric lymph node lymphangiogenesis

Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events

Plasma Membrane-bound G Protein-coupled Bile Acid Receptor Attenuates Liver Ischemia/Reperfusion Injury Via the Inhibition of Toll-like Receptor 4 Signaling in Mice

Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma

Engineered antigen presenting cells and uses thereof

Combining PALM and SOFI for quantitative imaging of focal adhesions in living cells

CD4+ T cell activation and vascular normalization: Two sides of the same coin?

Engineering Lymphangiogenesis

Bioengineering approaches in immunotherapy

Protein engineering approaches for direct antigen targeting in CD8+ T cell inducing vaccines